Gavin P. Andrews

5.5k total citations · 1 hit paper
145 papers, 4.4k citations indexed

About

Gavin P. Andrews is a scholar working on Pharmaceutical Science, Materials Chemistry and Organic Chemistry. According to data from OpenAlex, Gavin P. Andrews has authored 145 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 82 papers in Pharmaceutical Science, 37 papers in Materials Chemistry and 21 papers in Organic Chemistry. Recurrent topics in Gavin P. Andrews's work include Drug Solubulity and Delivery Systems (64 papers), Advanced Drug Delivery Systems (30 papers) and Crystallization and Solubility Studies (27 papers). Gavin P. Andrews is often cited by papers focused on Drug Solubulity and Delivery Systems (64 papers), Advanced Drug Delivery Systems (30 papers) and Crystallization and Solubility Studies (27 papers). Gavin P. Andrews collaborates with scholars based in United Kingdom, China and United States. Gavin P. Andrews's co-authors include David S. Jones, Yiwei Tian, Osama A. Abu-Diak, Colin P. McCoy, Shu Li, Gavin Walker, Sean P. Gorman, A. David Woolfson, Karl Malcolm and Anne Marie Healy and has published in prestigious journals such as Biomaterials, Advanced Drug Delivery Reviews and Chemical Engineering Journal.

In The Last Decade

Gavin P. Andrews

142 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mucoadhesive polymeric platforms for controlled drug delivery

2008 635 citations Gavin P. Andrews, David S. Jones et al. European Journal of Pharmaceutics and Biopharmaceutics profile →

Peers

Countries citing papers authored by Gavin P. Andrews

Since Specialization

Citations

This map shows the geographic impact of Gavin P. Andrews's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gavin P. Andrews with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gavin P. Andrews more than expected).

Fields of papers citing papers by Gavin P. Andrews

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gavin P. Andrews. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gavin P. Andrews. The network helps show where Gavin P. Andrews may publish in the future.

Co-authorship network of co-authors of Gavin P. Andrews

This figure shows the co-authorship network connecting the top 25 collaborators of Gavin P. Andrews. A scholar is included among the top collaborators of Gavin P. Andrews based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gavin P. Andrews. Gavin P. Andrews is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Exploiting supercooled medium-chain lipids and surfactant combinations for solid-phase dominant nanostructured lipid carrier production 2025 ·Journal of Materials Chemistry B ·(unknown), (unknown), (unknown), Gavin P. Andrews, Sheiliza Carmali	0
2	Fatty Acid-Containing p(HEMA) Hydrogels; A Promising Coating Platform to Reduce Encrustation on Urinary Catheters 2025 ·Polymers ·David S. Jones, Gavin P. Andrews, (unknown), Brendan Gilmore	1
3	Mucoadhesive Polymeric Polyologels Designed for the Treatment of Periodontal and Related Diseases of the Oral Cavity 2024 ·Polymers ·Gavin P. Andrews, (unknown), David S. Jones	1
4	Recent Clinical Successes in Liposomal Nanomedicines 2023 ·Research Portal (Queen's University Belfast) ·Wenjie Gu, Gavin P. Andrews, Yiwei Tian	6
5	Photosensitiser-incorporated microparticles for photodynamic inactivation of bacteria 2023 ·Journal of Photochemistry and Photobiology B Biology ·Jessica Moore, (unknown), Gavin P. Andrews, Colin P. McCoy	4
6	A new mathematical model derived from transient (creep) analysis to estimate the vaginal retention of semi-solid dosage forms 2022 ·International Journal of Pharmaceutics ·David S. Jones, Tao Yu, Shu Li, (unknown), Gavin P. Andrews	3
7	Solvent-Assisted Hot Melt Extrusion of a Thermally Labile, High Melting Point Compound 2021 ·AAPS PharmSciTech ·(unknown), James E. Huckle, Jeffrey M. Katz, (unknown), Dominick Daurio, Gavin P. Andrews, (unknown), Fernando Alvarez‐Núñez	3
8	A non-opioid analgesic implant for sustained post-operative intraperitoneal delivery of lidocaine, characterized using an ovine model 2020 ·Biomaterials ·Darren Svirskis, (unknown), Manisha Sharma, (unknown), (unknown), Wiremu MacFater, Ahmed Barazanchi, Laura Bennet, (unknown), (unknown), Priyanka Agarwal, Satya Amirapu, Jacqueline A. Hannam, Gavin P. Andrews, Andrew Hill, David S. Jones	15
9	IVIVC for Extended Release Hydrophilic Matrix Tablets in Consideration of Biorelevant Mechanical Stress 2020 ·Pharmaceutical Research ·Valentyn Mohylyuk, (unknown), Gavin P. Andrews, (unknown)	10
10	Drug release from hydroxypropylcellulose gels cannot be statistically predicted from their viscometric and initial viscoelastic properties 2020 ·Carbohydrate Polymers ·David S. Jones, (unknown), Gavin P. Andrews	2
11	Development of Polycaprolactone-Based metronidazole matrices for intravaginal extended drug delivery using a mechanochemically prepared therapeutic deep eutectic system 2020 ·International Journal of Pharmaceutics ·Shu Li, (unknown), David S. Jones, Gavin P. Andrews	26
12	The development of an inline Raman spectroscopic analysis method as a quality control tool for hot melt extruded ramipril fixed-dose combination products 2019 ·International Journal of Pharmaceutics ·Gavin P. Andrews, David S. Jones, (unknown), (unknown), (unknown), Olivier Chevallier, Christopher Elliot, Anne Marie Healy, Jeremiah Kelleher, Atif Madi, (unknown), Yiwei Tian	29
13	Metformin Hydrochloride and Sitagliptin Phosphate Fixed-Dose Combination Product Prepared Using Melt Granulation Continuous Processing Technology 2019 ·AAPS PharmSciTech ·Jeremiah Kelleher, Atif Madi, (unknown), Yiwei Tian, Shu Li, (unknown), (unknown), David S. Jones, Gavin P. Andrews, Anne Marie Healy	14
14	Probing the Effects of Experimental Conditions on the Character of Drug-Polymer Phase Diagrams Constructed Using Flory-Huggins Theory 2014 ·Pharmaceutical Research ·Conor Donnelly, Yiwei Tian, Catherine B. Potter, David S. Jones, Gavin P. Andrews	51
15	Novel semi-interpenetrating hydrogel networks with enhanced mechanical properties and thermoresponsive engineered drug delivery, designed as bioactive endotracheal tube biomaterials 2012 ·European Journal of Pharmaceutics and Biopharmaceutics ·David S. Jones, Gavin P. Andrews, (unknown), (unknown), Sean P. Gorman, Colin P. McCoy	42
16	Hot-Melt Extrusion Technology: optimising drug delivery 2010 ·Research Portal (Queen's University Belfast) ·(unknown), David Jones, Yü Tian, Gavin P. Andrews	8
17	Triggered drug delivery from biomaterials 2010 ·Expert Opinion on Drug Delivery ·Colin P. McCoy, Christopher J. Brady, (unknown), (unknown), Niamh McGoldrick, (unknown), Gavin P. Andrews, David S. Jones	68
18	Selection of an analytical method for evaluating bovine serum albumin concentrations in pharmaceutical polymeric formulations 2009 ·Journal of Pharmaceutical and Biomedical Analysis ·Manish Umrethia, Victoria Kett, Gavin P. Andrews, Karl Malcolm, A. David Woolfson	34
19	Stability of 5-aminolevulinic acid in novel non-aqueous gel and patch-type systems intended for topical application 2005 ·Journal of Pharmaceutical Sciences ·Paul A. McCarron, Ryan F. Donnelly, Gavin P. Andrews, A. David Woolfson	25
20	Non-drug treatments of hypertension 1982 ·BMJ ·Gavin P. Andrews, (unknown), (unknown), Declan Byrne	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact